Description
BSE announces the upcoming listing and admission to trading of equity shares of Sudeep Pharma Limited with scrip code 544619 and symbol SUDEEPPHRM.
Summary
BSE has announced that equity shares of Sudeep Pharma Limited will be listed and admitted to dealings on the Exchange in due course. The company has been assigned scrip code 544619 and trading symbol SUDEEPPHRM with ISIN number INE0QPI01025. The specific listing date and security details will be communicated through a separate notice.
Key Points
- Company Name: Sudeep Pharma Limited
- Scrip Code: 544619
- Trading Symbol: SUDEEPPHRM
- ISIN Number: INE0QPI01025
- Listing status: Approved, awaiting commencement date
- Specific listing date to be announced separately
Regulatory Changes
No regulatory changes. This is a new listing notification.
Compliance Requirements
Trading members are informed to note the scrip details for future reference. No immediate action required until the listing date is announced.
Important Dates
- Notice Date: November 27, 2025
- Listing Date: To be announced through separate notice
Impact Assessment
This is a routine new company listing announcement with minimal immediate market impact. Trading members should note the scrip details for when trading commences. Investors interested in Sudeep Pharma Limited should await the separate notice announcing the actual listing date and security details before any trading activity can begin.
Impact Justification
Routine new company listing announcement with listing date to be notified separately. Limited immediate market impact as trading has not yet commenced.